These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 23760586)

  • 1. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
    Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
    Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can preoperative and postoperative CEA predict survival after colon cancer resection?
    Slentz K; Senagore A; Hibbert J; Mazier WP; Talbott TM
    Am Surg; 1994 Jul; 60(7):528-31; discussion 531-2. PubMed ID: 8010568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia.
    Gara S; Meziou S; Mtar A; Ghanem A; Harzallah L; Rahal K; Boussen H; Guemira F
    Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
    Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
    J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
    Park JY; Lee KH
    Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
    Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
    J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.